- Home
- MYSZ vs RDHL Comparison
MYSZ vs RDHL Comparison
Compare MYSZ & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MYSZ | RDHL |
|---|---|---|
| Founded | 1999 | 2009 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 3.3M |
| IPO Year | 2017 | 2012 |
Fundamental Metrics
Financial Performance| Metric | MYSZ | RDHL |
|---|---|---|
| Price | $1.72 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 675.0K | ★ 2.5M |
| Earning Date | 04-15-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,000.00 | N/A |
| Revenue This Year | $41.64 | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 125.40 | N/A |
| 52 Week Low | $0.33 | $0.52 |
| 52 Week High | $4.28 | $2.79 |
Technical Indicators
Market Signals| Indicator | MYSZ | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 34.51 |
| Support Level | $0.50 | N/A |
| Resistance Level | $2.60 | $1.07 |
| Average True Range (ATR) | 0.25 | 0.04 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 10.00 | 0.00 |
Price Performance
Historical ComparisonAbout MYSZ My Size Inc.
My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.
About RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.